190 related articles for article (PubMed ID: 16847423)
1. Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women.
Gaudet MM; Chanock S; Lissowska J; Berndt SI; Yang XR; Peplonska B; Brinton LA; Welch R; Yeager M; Bardin-Mikolajczak A; Sherman ME; Sutter TR; Garcia-Closas M
Pharmacogenet Genomics; 2006 Aug; 16(8):547-53. PubMed ID: 16847423
[TBL] [Abstract][Full Text] [Related]
2. CYP1B1 and predisposition to breast cancer in Poland.
Matyjasik J; Cybulski C; Masojć B; Jakubowska A; Serrano-Fernandez P; Górski B; Debniak T; Huzarski T; Byrski T; Gronwald J; Złowocka E; Narod SA; Scott R; Lubinski J
Breast Cancer Res Treat; 2007 Dec; 106(3):383-8. PubMed ID: 17458695
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive assessment of genetic variation of catechol-O-methyltransferase and breast cancer risk.
Gaudet MM; Chanock S; Lissowska J; Berndt SI; Peplonska B; Brinton LA; Welch R; Yeager M; Bardin-Mikolajczak A; Garcia-Closas M
Cancer Res; 2006 Oct; 66(19):9781-5. PubMed ID: 17018638
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk.
Rylander-Rudqvist T; Wedren S; Granath F; Humphreys K; Ahlberg S; Weiderpass E; Oscarson M; Ingelman-Sundberg M; Persson I
Carcinogenesis; 2003 Sep; 24(9):1533-9. PubMed ID: 12844487
[TBL] [Abstract][Full Text] [Related]
5. Association of functionally important polymorphisms in cytochrome P4501B1 with lung cancer.
Shah PP; Singh AP; Singh M; Mathur N; Mishra BN; Pant MC; Parmar D
Mutat Res; 2008 Aug; 643(1-2):4-10. PubMed ID: 18573508
[TBL] [Abstract][Full Text] [Related]
6. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.
Haiman CA; Stram DO; Pike MC; Kolonel LN; Burtt NP; Altshuler D; Hirschhorn J; Henderson BE
Hum Mol Genet; 2003 Oct; 12(20):2679-92. PubMed ID: 12944421
[TBL] [Abstract][Full Text] [Related]
8. Association of cytochrome P450 1B1 haplotypes with head and neck cancer risk.
Katiyar T; Maurya SS; Hasan F; Singh AP; Khan AJ; Hadi R; Singh S; Bhatt MLB; Parmar D
Environ Mol Mutagen; 2017 Jul; 58(6):443-450. PubMed ID: 28556360
[TBL] [Abstract][Full Text] [Related]
9. Glaucoma-associated CYP1B1 mutations share similar haplotype backgrounds in POAG and PACG phenotypes.
Chakrabarti S; Devi KR; Komatireddy S; Kaur K; Parikh RS; Mandal AK; Chandrasekhar G; Thomas R
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5439-44. PubMed ID: 18055790
[TBL] [Abstract][Full Text] [Related]
10. The CYP1B1_1358_GG genotype is associated with estrogen receptor-negative breast cancer.
Justenhoven C; Pierl CB; Haas S; Fischer HP; Baisch C; Hamann U; Harth V; Pesch B; Brüning T; Vollmert C; Illig T; Dippon J; Ko YD; Brauch H
Breast Cancer Res Treat; 2008 Sep; 111(1):171-7. PubMed ID: 17922187
[TBL] [Abstract][Full Text] [Related]
11. Leu432Val polymorphism in CYP1B1 as a susceptible factor towards predisposition to primary open-angle glaucoma.
Bhattacharjee A; Banerjee D; Mookherjee S; Acharya M; Banerjee A; Ray A; Sen A; ; Ray K
Mol Vis; 2008 May; 14():841-50. PubMed ID: 18483560
[TBL] [Abstract][Full Text] [Related]
12. Association of CYP1B1 gene polymorphisms with susceptibility to endometrial cancer: a meta-analysis.
Wang F; Zou YF; Sun GP; Su H; Huang F
Eur J Cancer Prev; 2011 Mar; 20(2):112-20. PubMed ID: 21191305
[TBL] [Abstract][Full Text] [Related]
13. Variant alleles of the CYP1B1 gene are associated with colorectal cancer susceptibility.
Trubicka J; Grabowska-Kłujszo E; Suchy J; Masojć B; Serrano-Fernandez P; Kurzawski G; Cybulski C; Górski B; Huzarski T; Byrski T; Gronwald J; Złowocka E; Kładny J; Banaszkiewicz Z; Wiśniowski R; Kowalska E; Lubinski J; Scott RJ
BMC Cancer; 2010 Aug; 10():420. PubMed ID: 20701755
[TBL] [Abstract][Full Text] [Related]
14. CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis.
Zhang H; Li L; Xu Y
PLoS One; 2013; 8(7):e68634. PubMed ID: 23861929
[TBL] [Abstract][Full Text] [Related]
15. No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects.
Yao L; Fang F; Wu Q; Zhong Y; Yu L
Breast Cancer Res Treat; 2010 Jul; 122(1):237-42. PubMed ID: 20033481
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms in cytochrome P4501B1 and susceptibility to head and neck cancer.
Singh AP; Shah PP; Mathur N; Buters JT; Pant MC; Parmar D
Mutat Res; 2008 Mar; 639(1-2):11-9. PubMed ID: 18067928
[TBL] [Abstract][Full Text] [Related]
17. Association of CYP1B1 haplotypes and breast cancer risk in Caucasian women.
Huang Y; Trentham-Dietz A; García-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1321-3. PubMed ID: 19293312
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population.
Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
Arch Toxicol; 2002 Nov; 76(11):643-9. PubMed ID: 12415427
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
[TBL] [Abstract][Full Text] [Related]
20. Association of CYP1B1 polymorphisms and breast cancer risk.
De Vivo I; Hankinson SE; Li L; Colditz GA; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):489-92. PubMed ID: 12010864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
